Pfizer Inc "didn't conspire with anyone" to delay release of efficacy results for the COVID-19 vaccine it developed with German partner BioNTech SE until after the US presidential election, Chief Executive Albert Bourla said on Tuesday.
The companies' representatives also reported that the vaccine was well-tolerated.
BioNTech's logo is seen through a 3D-printed Pfizer logo in this illustration taken November 10, 2020.
She said in question period that 1.6 million doses of the Pfizer and 800,000 of the Moderna vaccines are destined for Ontario.
In a joint statement, both companies said on Wednesday that a completed analysis of their vaccine found it protected 95 percent of people against the disease.More news: Reverse Retro: Oilers alternate jersey for upcoming season unveiled
Pfizer's COVID-19 vaccine, which the company announced had completed clinical trials on Wednesday, could be approved for use in Canada as soon as January, when Health Canada's chief medical adviser said she thinks the department will have completed its review.
Final results from Pfizer's trials indicates an efficacy rate of 95 per cent, while Moderna's preliminary results are about the same.
In adults aged over 65 years, the observed efficacy was over 94%, with consistent efficacy rates across age, gender, race and ethnicity demographics. The other 162 were among participants in the placebo group who received a dummy shot. Fatigue and headaches have been reported as side effects in less than 4 percent of participants.
"The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic", Dr. Albert Bourla, Pfizer chairman and CEO, said in a statement.
Pfizer and BioNTech added that there were no serious safety concerns.More news: Apple to Pay $113 Million to Resolve Claims Over iPhone Battery
Both vaccine candidates use a new technology known as messenger RNA, or mRNA.
Concerns have been raised that it would be hard to distribute the BioNTech/Pfizer vaccine because it needs to be stored at around minus 75 degrees Celsius.
Tyrrell says the virus is more risky than any side-effects you may endure from the vaccine, encouraging all Albertan's to take it, when its readily available.
Pfizer and BioNTech have also developed thermal shippers utilizing dry ice to maintain temperature conditions at around minus 70 C, with the packaging able to serve as temporary storage units for 15 days if refilled with dry ice, according to their press release. The company said on Monday that its vaccine could be stored in the freezer for up to 30 days, not 7 as previously thought, which could make it easier to store than the Pfizer vaccine.More news: Mourinho takes dig at global break as Doherty tests COVID positive